Evidence map›Paper›PMID 34158421›Full record

ArticleMolecules and cells2021

Integrated Quantitative Phosphoproteomics and Cell-based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-related Phosphorylation Sites.

Hye Kyeong Kwon, Hyunwoo Choi, Sung-Gyoo Park, Woo Jin Park, Do Han Kim, Zee-Yong Park

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Phosphoproteomics Profile of Chicken Cecum in the Response toAnimals : an open access journal from MDPI · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hye Kyeong KwonSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID https://orcid.org/0000-0001-8133-0383
Hyunwoo ChoiSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID https://orcid.org/0000-0002-1130-9121
Sung-Gyoo ParkSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID https://orcid.org/0000-0003-3702-5765
Woo Jin ParkSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID https://orcid.org/0000-0002-3236-2212
Do Han KimSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID https://orcid.org/0000-0002-3390-5469
Zee-Yong ParkSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID https://orcid.org/0000-0002-8184-5982
Gwangju Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac hypertrophic signaling cascades resulting in heart failure diseases are mediated by protein phosphorylation. Recent developments in mass spectrometry-based phosphoproteomics have led to the identification of thousands of differentially phosphorylated proteins and their phosphorylation sites. However, functional studies of these differentially phosphorylated proteins have not been conducted in a large-scale or high-throughput manner due to a lack of methods capable of revealing the functional relevance of each phosphorylation site. In this study, an integrated approach combining quantitative phosphoproteomics and cell-based functional screening using phosphorylation competition peptides was developed. A pathological cardiac hypertrophy model, junctate-1 transgenic mice and control mice, were analyzed using label-free quantitative phosphoproteomics to identify differentially phosphorylated proteins and sites. A cell-based functional assay system measuring hypertrophic cell growth of neonatal rat ventricle cardiomyocytes (NRVMs) following phenylephrine treatment was applied, and changes in phosphorylation of individual differentially phosphorylated sites were induced by incorporation of phosphorylation competition peptides conjugated with cell-penetrating peptides. Cell-based functional screening against 18 selected phosphorylation sites identified three phosphorylation sites (Ser-98, Ser-179 of Ldb3, and Ser-1146 of palladin) displaying near-complete inhibition of cardiac hypertrophic growth of NRVMs. Changes in phosphorylation levels of Ser-98 and Ser-179 in Ldb3 were further confirmed in NRVMs and other pathological/physiological hypertrophy models, including transverse aortic constriction and swimming models, using site-specific phospho-antibodies. Our integrated approach can be used to identify functionally important phosphorylation sites among differentially phosphorylated sites, and unlike conventional approaches, it is easily applicable for large-scale and/or high-throughput analyses.

Indexed as

AnimalsCardiomegalyDisease Models, AnimalMiceMice, TransgenicPhosphorylationProteomicsSignal Transductioncardiac hypertrophycell-based functional screeningneonatal rat ventricle cardiomyocytesphosphorylation sitesquantitative phosphoproteomicstransgenic mice

Identifiers

PMID34158421
PMCPMC8334354
OpenAlexW3176104354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.